| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
91,200
|
— | ₹0.66 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 1,812,800 |
100% | ₹13.05 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 91,200 | ₹0.66 |
5.03%
|
| Total | 1,812,800 | ₹13.05 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 3,200 | ₹230,400 |
| Retail (Max — 13 Lots) | 13 | 20,800 | ₹1,497,600 |
| S-HNI (Min — 14 Lots) | 14 | 22,400 | ₹1,612,800 |
| B-HNI (Min — 68 Lots) | 68 | 108,800 | ₹7,833,600 |
| Particulars | 30-Sep-22 | 31-Mar-22 | 31-Mar-21 |
|---|---|---|---|
| Revenue from Operations | 12907.49 | 16603.29 | 16722.96 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 258.90 | 146.17 | 107.57 |
| Net Worth | 1743.15 | 1484.25 | 1338.08 |
| Total Assets | 10869.14 | 7700.16 | 8141.73 |
| Reserves & Surplus | 1243.65 | 984.75 | 838.58 |
| Borrowings | 2935.53 | 2548.43 | 2224.77 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Aristo Bio-Tech & Lifescience Ltd. IPO is subscribed 1.00 times by Jan 19, 2023. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Aristo Bio-Tech & Lifescience Ltd. IPO retail category is subscribed 1.00 times as of 19 Jan 2023. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 16 Jan 2023 and closes 19 Jan 2023. Min investment: ₹115,200 (1 lot = 1,600 shares). UPI mandate: 2023-01-19.
The Aristo Bio-Tech & Lifescience Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (MUFG Intime India Pvt.Ltd) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 24 Jan 2023. Refunds: on 25 Jan 2023.
The Aristo Bio-Tech & Lifescience Ltd. IPO listing date is 30 Jan 2023, Monday. Listed on: NSE SME. Issue price: ₹72. Estimated listing: ₹72. GMP: NIL.
The Aristo Bio-Tech & Lifescience Ltd. IPO closes on 19 Jan 2023, Thursday. UPI mandate: 2023-01-19. Allotment: 24 Jan 2023. Listing: 30 Jan 2023.